机译:埃博拉病毒VP35具有新的NTPAse和Liricase样活动
Wuhan Univ Coll Life Sci State Key Lab Virol Wuhan 430072 Hubei Peoples R China;
Chinese Acad Sci Inst Pasteur Shanghai CAS Key Lab Mol Virol &
Immunol Unit Viral Hepatitis Shanghai 200031 Peoples R China;
Wuhan Univ Coll Life Sci State Key Lab Virol Wuhan 430072 Hubei Peoples R China;
Univ Chinese Acad Sci Beijing 100049 Peoples R China;
Wuhan Univ Coll Life Sci State Key Lab Virol Wuhan 430072 Hubei Peoples R China;
Wuhan Univ Coll Life Sci State Key Lab Virol Wuhan 430072 Hubei Peoples R China;
Wuhan Univ Coll Life Sci State Key Lab Virol Wuhan 430072 Hubei Peoples R China;
Univ Chinese Acad Sci Beijing 100049 Peoples R China;
Wuhan Univ Coll Life Sci State Key Lab Virol Wuhan 430072 Hubei Peoples R China;
Chinese Acad Sci Inst Pasteur Shanghai CAS Key Lab Mol Virol &
Immunol Unit Viral Hepatitis Shanghai 200031 Peoples R China;
Wuhan Univ Coll Life Sci State Key Lab Virol Wuhan 430072 Hubei Peoples R China;
机译:埃博拉病毒VP35具有新的NTPAse和Liricase样活动
机译:埃博拉病毒VP35具有新颖的NTPase和类解旋酶活性
机译:杆状病毒表达的埃博拉病毒VP35和核蛋白的血清反应性
机译:通过化学交联和质谱探测埃博拉病毒VP35蛋白质结构
机译:VP35蛋白对埃博拉病毒聚合酶表达的严格调节。
机译:埃博拉病毒VP35具有新颖的NTPase和解旋酶样活性
机译:埃博拉病毒VP35通过其C末端干扰素抑制域拮抗PKR活性▿
机译:Vp35敲减抑制埃博拉病毒扩增并保护小鼠免受致命感染